chronic reserpin rat possibl model cystic fibrosi vi synergist effect isoproterenol ca protein submaxillari gland elev calcium protein concentr consist abnorm submaxillari saliva patient cystic fibrosi cf experiment anim model develop chronic administr either isoproterenol ipr reserpin possibl effect two drug may addit wa investig assess combin effect glandular salivari c protein rat submaxillari gland individu effect also assess relat dose use result indic 1 treatment 7 day 005 050 50 mgkg daili dose reserpin caus respect 45 95 120 increas glandular ca 93 165 374 increas glandular protein 2 treatment 7 day 50 mgkg daili dose isoproterenol caus 138 increas gland ca 1238 increas gland protein treatment 50 mgrat daili dose thi drug caus increas 166 103 gland ca protein 3 experi involv combin two drug isoproterenol wa administ 50 mgkg daili dose day 17 reserpin 05 mgkg daili dose day 410 treatment schedul thi procedur result 217 increas gland ca 257 increas gland protein b mark accumul granular basophil materi acinar cell develop intraduct precipit c secret turbid saliva high ca protein concentr secretori dose isoproterenol thi type stimul also reduc gland ca 50 protein 20 content produc vacuol acinar cell secret saliva elev ca protein respons pilocarpin elev concentr howev onefifth obtain isoproterenol stimul e secret smaller volum saliva type stimul find indic ipr reserpin doserel signific effect submaxillari gland ca protein individu effect synergist implic thi synerg physiolog state submaxillari gland secretori abnorm cystic fibrosi discuss